Invidia Capital Management, a healthcare investment firm founded by
former Goldman Sachs partner Jo Natauri, has announced its launch
with a strategic investment from GCM Grosvenor, a leading global
alternative asset management solutions provider.
Natauri brings over 25 years of healthcare investing, operating,
and investment banking experience to Invidia. She most recently
served as Global Head of Private Healthcare Investing at Goldman
Sachs, from which she departed in December 2023 after 17 years with
the firm. Invidia has assembled an impressive team of senior
advisors with deep knowledge and experience in the $4.5+ trillion
healthcare sector. Since the firm’s inception, Natauri has built a
highly experienced team with expertise in operations, strategy, and
deal execution. Jo has hired Vince Cuticello as Chief
Administrative Officer and Chief Compliance Officer, Alice Kennon
as Head of Operations and Capital Formation and six additional
investment team members with experience at Goldman Sachs, TPG, KKR,
Barclays, Partners Group, and Ontario Municipal Employees
Retirement System.
Invidia will focus on upper-middle market investment
opportunities where it believes that cost containment,
quality, access, and innovation are well-positioned to address some
of the most pressing global healthcare challenges and,
consequently, where such assets are best poised for sustained,
long-term growth.
"We are thrilled to unveil Invidia and our vision to build a
differentiated healthcare investment platform that will offer
comprehensive and thoughtful solutions to founders and management
teams as they endeavor to grow their businesses and best serve
their stakeholders. As the healthcare industry becomes increasingly
complex, we believe we are well-positioned by virtue of our
expertise, networks, and experience of investing in the sector to
deliver unique value to our CEO partners and investors,” Natauri
announced. “We are fortunate to have GCM Grosvenor as a
strategic partner at launch, given their track record of success in
identifying and supporting world-class investment talent, and we
are committed to making Invidia a leading force in healthcare
innovation."
In addition to her role as partner and Global Head of Private
Healthcare Investing, Natauri was an active member of Goldman
Sachs’ Corporate Investment Committee, Sustainable Investing
Investment Committee, and Life Sciences Investing Committee. She
has served on the boards of healthcare investments Avantor,
Parexel, MyEyeDr, MDVIP, and MedVet, among others.
“Healthcare is a rewarding sector for investors; it serves a
critical role for patients, their families, and society. Success
requires a firm like Invidia, which can partner on capital,
content, and connections to deliver value in a highly specialized
sector. Jo’s goal for Invidia was to build a firm that creates
value while having an impact, making this a special opportunity for
leaders who aspire to leave a mark.” said Meghan FitzGerald,
professor, investor, and Tenet Healthcare board member, who joined
Invidia as an early advisor.
Elizabeth Browne, Co-Head of GCM Grosvenor's Elevate strategy,
said, "Jo and her partners are emblematic of the quality,
integrity, and depth of expertise we seek when establishing
strategic partnerships. We are confident that Invidia is building
something special in the healthcare sector and are humbled to have
the opportunity to be a part of their story.”
Elevate strategy Co-Head, Kevin Nickelberry added, “Jo’s career
experience, domain expertise, and network have uniquely prepared
her to build and lead a world-class healthcare investment firm
successfully. We are excited to partner with her and the Invidia
team to support their vision.”
As of March 31, 2024, GCM Grosvenor had approximately $20
billion of assets under management ("AUM") invested with small and
emerging managers and roughly $16 billion of AUM with diverse
managers.
About Invidia Capital ManagementInvidia Capital
Management is a private equity firm primarily focused on
upper-middle market investment opportunities in North America.
Specializing in healthcare services, Invidia is dedicated to
supporting industry leaders and companies committed to enhancing
cost-effectiveness, quality, and accessibility, all while driving
innovation. Led by Jo Natauri, a healthcare industry investment
veteran, Invidia brings together an experienced team across
investing, operations, and strategy. Headquartered in New York,
Invidia Capital Management is poised to significantly contribute to
the advancement and success of its portfolio companies and the
broader healthcare landscape.
About GCM Grosvenor GCM Grosvenor (Nasdaq:
GCMG) is a global alternative asset management solutions provider
with approximately $79 billion in assets under management across
private equity, infrastructure, real estate, credit, and absolute
return investment strategies. The firm has specialized in
alternatives for more than 50 years and is dedicated to delivering
value for clients by leveraging its cross-asset class and flexible
investment platform. GCM Grosvenor's experienced team of
approximately 550 professionals serves a global client base of
institutional and individual investors. The firm is headquartered
in Chicago, with offices in New York, Toronto, London, Frankfurt,
Tokyo, Hong Kong, Seoul, and Sydney. For more information,
visit gcmgrosvenor.com.
Media Contacts
GCM GrosvenorTom Johnson and Abigail RuckH/Advisors Abernathy
tom.johnson@h-advisors.global /
abigail.ruck@h-advisors.global212-371-5999
Invidia Capital ManagementJay Kolbe
jkolbe@impactpartners.llc
GCM Grosvenor (NASDAQ:GCMG)
Historical Stock Chart
From Oct 2024 to Nov 2024
GCM Grosvenor (NASDAQ:GCMG)
Historical Stock Chart
From Nov 2023 to Nov 2024